CPBIO Holding Company Limited (HKG:3839)
8.37
-0.03 (-0.36%)
Sep 18, 2026, 3:58 PM HKT
CPBIO Holding Company Market Cap
CPBIO Holding Company has a market cap or net worth of 2.12 billion as of September 18, 2026. Its market cap has decreased by -10.96% in one year.
Market Cap
2.12B
Enterprise Value
2.68B
Revenue
3.32B
Ranking
n/a
PE Ratio
11.07
Stock Price
8.37
ChartMarket Cap Chart
Since July 3, 2015, CPBIO Holding Company's market cap has increased from 1.45B to 2.12B, an increase of 46.58%. That is a compound annual growth rate of 3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.12B | 15.45% |
| Dec 31, 2025 | 1.84B | 386.58% |
| Dec 31, 2024 | 377.46M | 56.84% |
| Dec 29, 2023 | 240.66M | 43.94% |
| Dec 30, 2022 | 167.20M | -52.17% |
| Dec 31, 2021 | 349.59M | -0.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tong Ren Tang Chinese Medicine Company | 4.73B |
| CF PharmTech | 4.47B |
| Edding Genor Group Holdings | 3.30B |
| Hua Medicine (Shanghai) | 2.30B |
| VISEN Pharmaceuticals | 2.08B |
| Jacobson Pharma Corporation | 1.93B |
| Dawnrays Pharmaceutical (Holdings) | 1.48B |
| Golden Throat Holdings Group Company | 1.43B |